Nature of Query:

The National Stock Exchange of India Limited raised a query through letter no. NSE/CM/Surveillance/17410 dated August 26, 2026 regarding price movement of the company's scrip.

Company Response / Clarification:

The company stated that it has made all necessary disclosures in a timely and accurate manner in conformity with Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015.

Regarding the price movement, the company clarified that such movement is attributable to:

  • Market conditions
  • Demand-supply dynamics
  • Trading activity of existing and prospective investors

The company emphasized that the price movement is entirely market-driven and that the company and/or its management have no connection with, control over, or role in such movement on the stock exchange platform.

Important contextual information provided:

  • Trading in the company's equity shares remained suspended for approximately 1.5 years due to procedural requirements arising from capital reduction undertaken by the company
  • Trading resumed with effect from 11.08.2026
  • Following resumption after prolonged suspension, there may have been increased investor interest and trading activity
  • This increased activity may have resulted in heightened demand and consequent volatility/movement in market price

The company confirmed it has not withheld any material information or event that may have a bearing on the price or volume behavior of its shares.

Regulatory Reference / Compliance:

The company explicitly references Regulation 30 of the SEBI (LODR) Regulations, 2015 and affirms its adherence to these requirements. The company commits to keeping the stock exchange duly informed of any information as required under the regulation as and when such events occur.

Analyst Perspective / Material Implications:

No material financial metrics, operational updates, or strategic insights were disclosed in this clarification. The response focuses solely on addressing the price movement query and affirming regulatory compliance.